Investing.com - Cigna Corp (NYSE:CI) has confirmed it is not pursuing a combination with its smaller peer Humana (NYSE:HUM), ...
In a report released yesterday, Erin Wright from Morgan Stanley maintained a Buy rating on Cigna (CI – Research Report), with a price ...
Analyst Steve Baxter of Wells Fargo maintained a Hold rating on Cigna (CI – Research Report), retaining the price target of $355.00.
Cigna Group confirmed it is "not pursuing a combination with Humana, a big provider of Medicare Advantage coveage.
Last December, the two companies failed to agree on a price as Cigna pursued the purchase of the Louisville-based company.
Shares of Humana Inc. ($HUM) dipped by as much as 4%, while shares of Cigna Corp. ($CI) rose by over 7% as markets opened on ...
Shares of The Cigna Group CI jumped 7.3% yesterday after it clarified in a press release that it's not pursuing a merger with ...
UnitedHealth Group Inc. shares rose as much as 9.3% before U.S. markets opened, while shares of Humana Inc. gained as much as ...
Current price $321.13 52-week high $370.83 ...
Cigna's bold move to halt merger talks with Humana sends shockwaves through the market, while stock buybacks ramp up.
Humana shares are tumbling in premarket trading Monday after The Cigna Group said it is not pursuing a merger with its smaller health insurance rival.